Consort Medical

Company

Who we are

Consort Medical is a leading global contract development and manufacturing organisation (CDMO), providing advanced delivery technologies, formulation and manufacturing solutions for drugs.

Our customers include some of the world’s largest pharmaceutical companies. Optimising world-class drug delivery device development and manufacture, together with drug Active Pharmaceutical Ingredient (API) and finished dose formulation and manufacture, within the same Group streamlines and accelerates our pharmaceutical customers’ drug route to market.
Consort Medical is at the leading edge of innovation and is committed to investing in patient and customer driven innovation, with the potential to create new treatments, new markets and new opportunities.

We also continue to diversify into adjacent complementary markets and technologies which leverage our core competencies in drug formulation, manufacturing and delivery.
The Group comprises two integrated operating divisions:

Bespak Drug Delivery Devices — a global market leader in the development and manufacture of drug delivery devices, serving pharmaceutical companies with inhaler and auto-injector technologies and development and manufacturing services.

Aesica Development & Manufacture API & Finished Dose — a leading pharmaceutical CDMO serving pharmaceutical companies with active pharmaceutical ingredient (API) and finished dose formulation development and manufacturing services.

Optimising world-class drug delivery device development and manufacture, together with drug API and finished dose formulation and manufacture, within the Group streamlines and accelerates our pharmaceutical customers’ drug route to market.

The combination of Bespak and Aesica businesses enables the Consort Medical group to provide its customers with a single source provider for medical and pharmaceutical devices and drug dosage forms. Our customers can now benefit from an unrivalled global offering; allowing us to deliver an exceptional value to the supply chain, from early stage device design and development and drug formulation to full market commercialization.

Bespak, a global market leader in the design, development and manufacture of drug delivery devices, provides inhaler, autoinjector and nasal technologies, as well as development and manufacturing services. Aesica, as a leading pharmaceutical CDMO, is renowned for developing and manufacturing APIs and finished dosage forms for the global pharmaceutical industry.

 

PIANEZZA-243

The core brand message focuses on delivery of early stage development to full manufacturing services that will help our customers to streamline complex supply chains and, in doing so, accelerate the route to market, reducing cost, complexity, and time for our customers. Your normal contacts remain in both businesses, and are here to better serve your needs.

Contact us for more information.

Contact